Your Best Stock
Stocks › Biotechnology › VRTX

Vertex Pharmaceuticals VRTX

US equityMarket cap rank #116BiotechnologyGene Editing
$521.79
+$5.45 (+1.05%)
Market open · Sep 24, 2:00 pm ET
After hours $517.00 +0.13%
Open$515.56
Prev close$516.34
Day range$515.30 – $528.89
Volume376.3K
Market cap$132.25B
P/E (TTM)30.4
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership97.2%-0.07 pts vs. prior quarter
Institutions holding2,104-6 vs. prior quarter
Insider trades (recent)9 buys / 11 sellsNet selling
Short interest1.84% of floatDays to cover 4.5 · as of 31 Aug 2026
Short-sale volume share18.3%5-day average of daily volume

Short-sale volume as % of daily volume

12%15%18%22%Aug '26Sep '26Sep '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$72.81M (15 inflow days, 5 outflow days).

Largest holders

  • Capital Research20.05%
  • BlackRock9.51%
  • Vanguard Capital Management, LLC7.10%
  • State Street Global Advisors4.68%
  • Invesco Capital Management LLC2.93%

By investor type

  • Mutual Fund86.79%
  • Public Company3.21%
  • Hedge Fund1.93%
  • Government Pension Fund1.88%
  • Private Company1.38%
  • Sovereign Wealth Fund1.26%
  • Insurance Company0.34%
  • Individual/Insider0.20%
Institutional holders2,104
Institutional ownership97.2%

Insider activity

Total transactions24
Bought9
Sold11

Short interest

Report dateShares short% of floatDays to cover
31 Aug 2026 4,659,749 1.8% 4.5
14 Aug 2026 4,146,973 1.6% 3.1
31 Jul 2026 3,942,936 1.6% 3.0
15 Jul 2026 4,986,691 2.0% 3.1
30 Jun 2026 4,938,472 1.9% 2.0
15 Jun 2026 4,616,968 1.8% 3.8
Scroll to Top